Let me first state my viewpoint: the root of these problems often does not lie in the RPA technology itself, but largely in the development and testing phases, which are the most fundamental yet often ...

FDA experts at PDA 2025 urges pharma to adopt holistic quality systems, strengthening 483 responses & post-warning letter remediation for compliance excellence.